Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

firstwordpharma.com
firstwordpharma.com > story > 7983565

AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial

1+ day, 1+ hour ago   (12+ words) firstwordpharma.com...

firstwordpharma.com
firstwordpharma.com > story > 7973027

Friday Five??? Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal???and more

3+ day, 7+ hour ago   (19+ words) Friday Five – Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal…and more firstwordpharma.com...

FirstWord PHARMA
firstwordpharma.com > story > 7972807

Takeda's R&D head Andy Plump to retire after back-to-back approvals

3+ day, 10+ hour ago   (13+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7969518

NodThera rebrands as Rezera, charts registrational path for PAD drug

4+ day, 1+ hour ago   (12+ words) FirstWord Pharma...

FirstWord PHARMA
firstwordpharma.com > story > 7969054

Schr??dinger forms I&I-focused newco with NEA, RA Capital

4+ day, 6+ hour ago   (11+ words) Schrödinger forms I&I-focused newco with NEA, RA Capital FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7967761

Solstice raises $225M to advance next-gen CTLA-4 immunotherapy

4+ day, 14+ hour ago   (10+ words) FirstWord Pharma...

firstwordpharma.com
firstwordpharma.com > story > 7958314

Vital Signs: Who's enjoying the fruits of pharma's labor?

6+ day, 14+ hour ago   (10+ words) firstwordpharma.com...

FirstWord Pharma
firstwordpharma.com > story > 7957772

Physician Views Preview: Can AstraZeneca's Etcamah carve out a new treatment paradigm in breast cancer?

6+ day, 19+ hour ago   (17+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7957440

Novo's hopes for ziltivekimab dwindle as two heart failure studies stopped early

6+ day, 22+ hour ago   (14+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7957147

FDA OKs withdrawal of colorectal cancer indication for BMS's Krazati

1+ week, 1+ hour ago   (12+ words) FirstWord Pharma...